accountIndia's Jubilant Biosys has struck a new research and development deal with AstraZeneca that ... in a separate development deal with Eli Lilly,...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to India's Jubilant inks $220M R&D deal with AZ
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account